An Australian first for lupin genome project
Being conducted in collaboration with the Centre for Food and Genomic Medicine (CFGM) in Perth, WA, the three-year, $1.5 million project will enable researchers and breeders to accelerate lupin crop improvements such as drought tolerance, disease resistance and optimal flowering time.
The research team will build upon established resources and employ powerful next-generation sequencing technologies and innovative bioinformatics techniques in their efforts to sequence the genome.
Lupins, members of the legume family, are a valuable winter rotation crop that farmers can use to prevent diseases surviving from season to season in cereal crops such as wheat. They have the added benefit of fixing nitrogen in the soil.
Lupins are also a good source of protein and dietary fibre and CSIRO scientists have already identified genes in lupins which produce proteins that impact on the nutritional content of the grain.
Studies conducted by the CFGM have shown these proteins have important wide ranging benefits for humans and may provide cardiovascular health benefits in terms of increasing insulin sensitivity and reducing blood pressure. The proteins could potentially reduce the risk of diabetes and obesity by increasing a person's sensitivity to insulin and creating the sensation of being 'full'.
Responsibility for overseeing the research project was awarded to the Western Australian Institute for Medical Research-based CFGM by the Grains Research and Development Corporation following a competitive national tender process.
The CFGM team will interact with national and international collaborators in China, Europe, Japan and the USA with sequencing and bioinformatic expertise to help gain and analyse the sequence data. The majority of the project will be conducted at the new CSIRO/University of Western Australia joint Crop Genomics laboratory at Floreat, in Perth WA and will be led by Prof Karam Singh (CSIRO/UWA).
The project’s results will be published online for public access benefiting lupin researchers, lupin breeders and the broader community.
-
Most popular related searches
Related news
-
CD Genomics Fully Supports Your Microbiome Research with Comprehensive Sequencing Solutions
CD Genomics is a leading services company committed to providing global customers with the most comprehensive analytic services, including a broad range of microbial genomic solutions to support research and development. The company announced microbiome profiling services, alongside bioinformatic analysis technology to help researchers understand the significance of human and animal microbiota. Through long-term and detailed studies of the gut microbiota, scientists have revealed the complex relationship...
-
Creative Enzymes Upgrades Multiple Diagnostic Enzyme Products for Clinical and Diagnostic Research
Creative Enzymes, the world’s leading diagnostic enzyme production company, has been committed to providing customers with various enzyme products and services for medical and research diagnosis. Relying on its professional team and the most advanced technology, as well as high-quality products and services, it has gained solid reputation. Recently, Creative Enzymes has announced multiple diagnostic enzyme products for diagnostics use. Creative Enzymes’s product line of diagnostic enzyme covers...
-
Asensus Surgical Announces FDA Clearance in General Surgery
Asensus Surgical, Inc. (formerly TransEnterix, Inc.) (NYSE American: TRXC) , a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced the Company has received an additional FDA clearance for the Senhance Surgical System which allows for indication expansion in general surgery in the United States. Asensus Surgical`s technology platform, Senhance® Surgical System, is the first of its kind digital...
-
How Often should you Take CBD?
How Often Should You Take CBD? How often should you take CBD? It’s a fairly common question, and although more research still needs to be conducted to get a better idea, we know that it’s perfectly safe to take CBD every day. CBD is a non-psychoactive cannabinoid harvested from the industrial hemp plant and has been known to assist in a variety of functions. So long as you stay within a proper dosage and take a high-quality product, regularly consuming CBD can have a number of benefits. The more...
-
Rutgers researcher invents Microbiota Formula to help high-risk patients fight Covid-19
A Rutgers scientist has invented an early treatment for COVID-19 to prevent severe complications and hospitalizations in patients with prediabetes and diabetes by increasing beneficial bacteria in the gut and reducing organisms that cause coronavirus. The treatment – created by researcher Liping Zhao – was given the Investigational New Drug status by the Food and Drug Administration and will start Phase 2a trial Feb. 8. While the treatment, NBT-NM108, does not target the coronavirus directly, it does...
Customer comments
No comments were found for An Australian first for lupin genome project. Be the first to comment!